Bovidip 20 mg/ml Concentrate for Teat Dip or Spray Solution
Bovidip 20 mg/ml Concentrate for Teat Dip or Spray Solution
Authorised
- Iodine (125I)
Product identification
Medicine name:
Bovidip 20 mg/ml Concentrate for Teat Dip or Spray Solution
Bovidip 2 % W/V Concentraat voor dipoplossing en Concentraat voor spray, oplossing
Bovidip 2 % W/V Solution à diluer pour trempage et Solution à diluer pour pulvérisation d'une solution
Bovidip 2 % W/V Konzentrat zur Herstellung eines Tauchbades, Lösung und Konzentrat zur Herstellung eines Sprays, einer Lösung
Active substance:
- Iodine (125I)
Target species:
-
Cattle
Route of administration:
-
Teat use
Product details
Active substance and strength:
-
Iodine (125I)2.00/gram(s)1.00millilitre(s)
Pharmaceutical form:
-
Teat dip/spray solution
Withdrawal period by route of administration:
-
Teat use
-
Cattle
-
Meat and offal0day
-
Milk0hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG52A
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- High-density polyethylene 5 litre cans closed with high-density polyethylene screw caps,secured with a sealing ring.
- High-density polyethylene 10 litre cans closed with high-density polyethylene screw caps,secured with a sealing ring.
- High-density polyethylene 20 litre cans closed with high-density polyethylene screw caps,secured with a sealing ring.
- High-density polyethylene 60 litre cans closed with high-density polyethylene screw caps,secured with a sealing ring.
- High-density polyethylene 200 litre cans closed with high-density polyethylene screw caps,secured with a sealing ring.The 200 litre container should not be returned for re-filling.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Delaval
Marketing authorisation date:
Manufacturing sites for batch release:
- Delaval
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V339893
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0484/001
Concerned member states:
-
Belgium
-
Netherlands
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 6/07/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
